Chris Ntoumenopoulos, Director at ResApp Health Limited, holds 6.06M shares in TrivarX Limited (Ticker: MDBIF), holds 3.61M shares in ResApp Health Limited (Ticker: AU:RAP), holds 1.04M shares in Race Oncology Ltd. (Ticker: AU:RAC).
What is the percentage of profitable transactions made by Chris Ntoumenopoulos?
The percentage of profitable transactions made by Chris Ntoumenopoulos is 80%.
What is the average return per transaction made by Chris Ntoumenopoulos?
The average return per transaction made by Chris Ntoumenopoulos is 279.50%.
What stocks does Chris Ntoumenopoulos hold?
Chris Ntoumenopoulos holds: AU:RAP, AU:RAC, MDBIF stocks.
What was Chris Ntoumenopoulos’s latest transaction?
Chris Ntoumenopoulos latest transaction was an Uninformative Buy of $45.00K.
What was Chris Ntoumenopoulos's most profitable transaction?
Chris Ntoumenopoulos’s most profitable transaction was an Informative Buy of AU:RAP stock on July 7, 2015. The return on the trade was 800.00%.
What is Chris Ntoumenopoulos's role in ResApp Health Limited?
Chris Ntoumenopoulos's role in ResApp Health Limited is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.